Minocycline for acne vulgaris: Efficacy and safety

Cochrane Database of Systematic Reviews

Volumn 2012, Issue 8, 2012, Pages

  Garner, Sarah E ^a   Eady, Anne ^b   Bennett, Cathy ^c   Newton, John Norman ^d   Thomas, Karen ^e   Popescu, Catalin Mihai ^f  

^a NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZELAIC ACID; BENZAMYCIN; BENZOYL PEROXIDE; CLINDAMYCIN; CYPROTERONE ACETATE PLUS ETHINYLESTRADIOL; DOXYCYCLINE; ERYTHROMYCIN PLUS ISOTRETINOIN; FROPENEM; FUSIDIC ACID; GLUCONATE ZINC; ISOTRETINOIN; JOSAMYCIN; LYMECYCLINE; MINOCYCLINE; OXYTETRACYCLINE; ROXITHROMYCIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TETRACYCLINE; ZINERYT; ANTIINFECTIVE AGENT;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACNE VULGARIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANCA ASSOCIATED VASCULITIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BRAIN PSEUDOTUMOR; DIARRHEA; DIZZINESS; DRESS SYNDROME; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; DRY SKIN; ENZYME BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERPIGMENTATION; INFLAMMATORY BOWEL DISEASE; LIVER DYSFUNCTION; LIVER INJURY; LUPUS ERYTHEMATOSUS; LUPUS LIKE SYNDROME; LUPUS VULGARIS; MAINTENANCE THERAPY; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; PIGMENT DISORDER; PRIORITY JOURNAL; REVIEW; SERUM SICKNESS; SEX DIFFERENCE; SKIN BURNING SENSATION; SKIN DEFECT; SKIN DISEASE; SKIN IRRITATION; STOMACH DISCOMFORT; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; VASCULITIS; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; HUMANS; MINOCYCLINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84866753885     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002086.pub2     Document Type: Review

References (191)

1. Blechschmidt J, Engst R, Hoting E, Klovekorn W, Maas B, Meinhof W, et al. Treatment of papulo-pustular acne- comparison of the efficacy and tolerance of minocycline and oxytetracycline [Behandlung der acne papulopustulosa -vergleich der wirksamkeit und verträglichkeit von minocyclin und oxytetracyclin]. Munchener Medizinische Wochenschrift 1987;129(29/30):562-4.
2. Bossuyt L, Bosschaert J, Richert B, Cromphaut P, Mitchell, T, Al Abadie M, et al. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline. European Journal of Dermatology 2003;13(2):130-5.
3. Bossuyt L, Richert B, Al Abadie M, Henry I, Bewley AP, Czernielewski J. Safety and efficacy comparison of lymecycline versus minocycline in the treatment of acne vulgaris [Abstract]. 11th Congress of the European Academy of Dermatology & Venereology; 2-6 October 2002, Prague. 2002:1-41.
4. Czernielewski J, Bossuyt L, Richert B, Al Abadie M, Henry I, Bewley AP. Safety and efficacy comparison of lymecycline versus minocycline in the treatment of acne vulgaris [Poster P0010]. Proceedings of 20th World Congress of Dermatology; 1-5 July 2002, Paris. 2002:1S372.
5. Cabezas AM, Jacial A, Rojas H. A double blind study of the effectiveness of minocycline compared with tetracycline or placebo in the treatment of inflammatory acne [Ensayo terapeutico con minocin]. Revista Chilena De Dermatologia 1993;9(1):6-11.
6. Campo M, Zuluaga A, Escobar P, Motta A, Argote A, Jaramillo C, et al. A comparative study on the effectiveness of lymecycline and minocycline and adapalene in the treatment of acne vulgaris [Poster P0005]. Proceedings of 20th World Congress of Dermatology; 1-5 July 2002, Paris. 2002:1S371.
7. Campo MH, Zuluaga A, Escobar P, Motta A, Argote A, Jaramillot C, et al. Efficacy and safety of lymecycline combined with adapalene gel and minocycline combined with adapalene in the treatment of acne vulgaris. [Abstract P1-15]. 12th Congress of the European Academy of Dermatology and Venereology. Barcelona, Spain 15-18th October 2003. Journal of the European Academy of Dermatology & Venereology 2003;17(Suppl 3):168.
8. Cullen SI, Cohan RH. Minocycline therapy in acne vulgaris. Cutis 1976;17(6):1208-10, 1214.
9. Cunliffe WJ, Grosshans E, Belaich S, Meynadier J, Alirezai M, Thomas L. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris. European Journal of Dermatology 1998;8(3):161-6.
10. Cunliffe WJ, et al. A comparison of the efficacy and safety of lymecycline and minocycline in acne [Abstract 5104]. The 19th World Congress of Dermatology 15-20 June, Sydney, 1997. Australasian Journal of Dermatology 1997;38(Suppl 2):261.
11. Darrah AJ, Gray PL. An open multicentre study to compare fusidic acid lotion and oral minocycline in the treatment of mild to moderate acne vulgaris of the face. European Journal of Clinical Research 1996;8:97-107.
12. Drake L. Comparative efficacy and tolerance of Cleocin T topical gel (clindamycin phosphate topical gel) versus oral minocycline in the treatment of acne vulgaris. Data on file (Technical Report from Pharmacia and Upjohn Ltd) 1990.
13. Dreno B (Department of Cancero-Dermatology, Hôtel Dieu, Nantes Cedex, France) Trial report [personal communication]. Letter to S Garner (NICE, London, UK) 22 October 1998.
14. Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001;203(2):135-40.
15. Fallica L, Vignini M, Rodeghiero R. Minocycline and tetracycline hydrochloride in the treatment of acne vulagris: comparative data [La minociclina e la tetraciclina cloridrato nel trattamento dell'acne volgare:dati comparativi]. Dermatologica Clinicia 1985;5(2):145-50.
16. Rabbiosi G, Marson G, Sapuppo A. Acne: minocycline and tetracycline treatment. Royal Society of Medicine Services International Congress & Symposium Series 1985;95:121-5.
17. Fleischer AB, Dinehart S, Stough D, Plott RT. Safety and efficacy of a new extended-release formulation of minocycline. Solodyn Phase, 2. Study Group, and Solodyn Phase, 3. Study Group. Cutis 2006;78(4 Suppl):21-31.
18. Fleischer AB, Dinehart S, Stough D, Plott RT. Safety and efficacy of a new extended-release formulation of minocycline. Solodyn Phase, 2. Study Group, and Solodyn Phase, 3. Study Group. Cutis 2006;78(4 Suppl):21-31.
19. Gollnick HPM, Graup K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. European Journal of Dermatology 2001;11(6):538-44.
20. Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil, RP Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis 1996;57(1 Suppl):20-35.
21. Harrison PV. A comparison of doxycycline and minocycline in the treatment of acne vulgaris. Clinical & Experimental Dermatology 1988;13(4):242-4.
22. Hayashi N, Kawashima M. Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem. Journal of Dermatology 2011;38(2):111-9.
23. Hersle K, Gisslen H. Minocycline in acne vulgaris: a double-blind study. Current Therapeutic Research 1976;19(3):339-42.
24. Hubbell CG, Hobbs ER, Rist T, White JW. Efficacy of minocycline compared with tetracycline in treatment of acne vulgaris. Archives of Dermatology 1982;118(12):989-92.
25. Khanna N. Treatment of acne vulgaris with oral tetracyclines. Indian Journal of Dermatology, Venereology & Leprology 1993;59(2):74-6.
26. Laux B. Treatment of acne vulgaris. A comparison of doxycycline versus minocycline [Behandlung der acne vulgaris-ein vergleich von doxycyclin versus minocyclin]. Hautarzt 1989;40(9):577-81.
27. Leyden J, Bergfeld W, Drake L, Dunlap F, Goldman MP, Gottlieb AB, et al. A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. Journal of the American Academy of Dermatology 2004;50(3):443-7.
28. Leyden J, Thiboutot DM, Shalita A, Webster G, Washenik K, Strober BE, et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicentre, double-blind, randomised parallel-group study. Archives of Dermatology 2006;142(5):605-12.
29. Lorette G, Belaich S, Beylot MC, Ortonne JP. Doxycycline (Tolexine) 50 mg/day versus minocycline 100 mg/day in the treatment of acne vulgaris. Evaluation on four months of treatment [Doxycycline (Tolexine) 50mg/jour versus minocycline 100mg/jour dans le traitement de l'acné juvénile. Evaluation sur quatr mois de traitement]. Nouvelles Dermatologiques 1994;13(9):662-5.
30. Monk BE, Almeyda JA, Caldwell IW. Efficacy of low-dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris. Clinical & Experimental Dermatology 1987;12(5):319-22.
31. Ólafsson JH, Gudgeirsson J, Eggertsdóttir GE, Kristjánsson F. Doxycycline versus minocycline in the treatment of acne vulgaris: a double-blind study. Journal of Dermatological Treatment 1989;1(1):15-7.
32. Kerst AJF. Acne vulgaris: comparison of five antimicrobial regimens [Acne vulgaris: vergelijking van vijf antimicrobiele regimens]. Geneesmiddelenbulletin 2005;39(6):68-9.
33. Ozolins M, Eady EA, Avery A, Cunliffe WJ, Li Wan Po A, O'Neill C, et al. A cost-effective rationale for the selection of antimicrobial therapy in acne: a randomized controlled trial [Abstract]. 11th Congress of the European Academy of Dermatology and Venereology; 2-6 October, Prague. 2002:P1-1.
34. Ozolins M, Eady EA, Avery A, Cunliffe WJ, Li Wan Po A, O'Neill C, et al. A cost-effectiveness rationale for the selection of antimicrobial therapy in acne: a randomized controlled trial [Abstract RF-2]. British Journal of Dermatology 2002;147(Suppl 62):13.
35. Ozolins M, Eady EA, Avery A, Cunliffe WJ, O'Neill C, Simpson NB, et al. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technology Assessment (Final HTA acne study report MO 24/03/04) 2005; Vol. 9, issue 1:iii-100.
36. Ozolins M, Eady EA, Avery AJ, Cunliffe PWJ, Wan Po PAL, O'Neill PC, et al. Comparison of five antmicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004;364(9452):2188-95.
37. Peacock CE, Price C, Ryan BE, Mitchell AD. Topical clindamycin (Dalacin T) compared to oral minocycline (Minocin 50) in treatment of acne vulgaris. A randomized observer-blind controlled trial in three university student health centres. Clinical Trials Journal 1990;27(3):219-28.
38. Pelfini C, Bonino S, Privitera G, Cerimele D, Venier A, Serri F. Josamycin versus minocycline in the treatment of papulopustular acne. Journal of Chemotherapy 1989;1(4 Suppl):921-3.
39. Pierard-Franchimont C, Goffin V, Arrese JE, Martalo O, Braham C, Slachmuylders P, et al. Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy. Skin Pharmacology & Applied Skin Physiology 2002;15(2):112-9.
40. Pigatto PD, Finzi AF, Altomare GF. Isotretinoin versus minocycline in cystic acne: a study of lipid metabolism. Dermatologica 1986;172(3):154-9.
41. Revuz JE, Guillaume JC, Poli F, Pouget F, Zeller J, Boitier F. Controlled trial of minocycline in acne patients. Royal Society of Medicine Services International Congress & Symposium Series 1985;95:103-8.
42. Ruping KW, Tronnier H. Acne therapy: results of a clinical multi-centre study with minocycline. Royal Society of Medicine Services International Congress & Symposium Series 1985;95:109-19.
43. Samuelson JS. An accurate photographic method for grading acne: initial use in a double-blind clinical comparison of minocycline and tetracycline. Journal of the American Academy of Dermatology 1985;12(3):461-7.
44. Schollhammer M, Alirezai M. Comparative study of lymecycline, minocycline and doxycycline in the treatment of acne vulgaris [Etude comparative de la lymécycline, de la minocycline et de la doxycycline dans le traitement de l'acné vulgaire]. Réalités Thérapeutiques en Dermato-Vénérologie 1994;42:24-6.
45. Sheehan-Dare RA, Papworth-Smith J, Cunliffe WJ. A comparative study between topical clindamycin and oral minocycline in the treatment of acne vulgaris. Round Table Series - Royal Society of Medicine 1989;19:24-8.
46. Sheehan-Dare RA, Papworth-Smith J, Cunliffe WJ. A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris. Acta Dermato-Venereologica 1990;70(6):534-7.
47. Smit F. Minocycline versus doxycycline in the treatment of acne vulgaris. Dermatologica 1978;157(3):186-90.
48. Stainforth J, MacDonald-Hull S, Papworth-Smith JW, Eady EA, Cunliffe WJ, Norris JFB, et al. A single-blind comparison of topical erythromycin/zinc lotion and oral minocycline in the treatment of acne vulgaris. Journal of Dermatological Treatment 1993;4(3):119-22.
49. Stewart DM, Torok HM, Weiss JS, Plott RT. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris. Cutis 2006;78(4 Suppl):11-20.
50. Waskiewicz W, Grosshans E. Treatment of acne vulgaris with cyclines of second generation: a comparison of doxycyline 50mg daily versus minocycline 100mg daily [Traitement de l'acné juvénile par les cyclines de deuxième génération: étude comparative randomisée doxycycline 50mg/jour versus minocycline 100mg/ jour]. Nouvelles Dermatologiques 1992;11:8-11.
51. Alberto N, Abubakar AA. Clinical trial of minocycline in the treatment of Filipino patients with acne vulgaris. Philippine Journal of Internal Medicine 1990;28(6):457-61.
52. Altieri E, Venturini D. Clinical findings on the therapeutic activity of minocycline in acne vulgaris [Rilievi clinici sull'attività terapeutica della minociclina nell'acne giovanile]. Dermatologia Clinica 1989;9(2):107-15.
53. Anonymous Extended-release minocycline (Solodyn) for acne. Medical Letter on Drugs & Therapeutics 2006;48(1248):95-6.
54. Arata J, Fujita S, Tokumaru S, Kodama H. Clinical experience with minocycline in the dermatological field (Japanese). Japanese Journal of Antibiotics 1969;22(6):480-2.
55. Arrese JE, Goffin V, Avila-Camacho M, Greimers R, Pierard GE. A pilot study on bacterial variability in acne. Assessment using dual flow cytometry on microbials present in follicular casts and comedones. International Journal of Dermatology 1998;37(6):461-464.
56. Barba JF, Jimenez Brito G, Hermoso I, Morales Ortiz R, Altamirano L. Effectiveness and safety of oral minocycline in treating acne vulgaris [Evaluación de la minociclina (minocin) en acné vulgaris inflamatorio]. Compendium de Investigaciones Clinicas Latinoamericanas 1989;9(3):99-107.
57. Barba Gómez JF, Morales Ortiz R. An evaluation of minocycline (minocin) in inflammatory acne vulgaris [Evaluación de la minociclina (minocin) en acné vulagris inflamatorio]. Investigación Médica Internacional 1990;16(4):240-4.
58. Becker FT. Treatment of tetracycline-resistant acne vulgaris. Cutis 1974;14(4):610-13.
59. Bodokh I, Jacomet Y, Lacour JP, Ortonne JP. Minocycline induces an increase in the number of excreting pilosebaceous follicles in acne vulgaris. A randomised study. Acta Dermato-Venereologica 1997;77(4):255-259.
60. Bok LB. Practical experience with minocycline. Royal Society of Medicine Services International Congress & Symposium Series 1985;95:83-6.
61. Clerico R, Cantoresi F, Bianchini D. Therapeutic activity of minocycline in patients with acne vulgaris [Attività terapeutica della minociclina in pazienti affetti da acne volgare]. Dermatologia Clinica 1984;4(4):341-9.
62. Cohen PM. A general practice study investigating the effect of Minocin 50 mg b.d. for 12 weeks in the treatment of acne vulgaris. Journal of International Medical Research 1985;13(4):214-21.
63. Coskey RJ. Acne: treatment with minocycline. Cutis 1976;17(4):799-801.
64. Cullen SI. Low-dose minocycline therapy in tetracycline-recalcitrant acne vulgaris. Cutis 1978;21(1):101-4.
65. Cullen SI. Treatment of tetracycline resistant acne vulgaris with minocycline in a low dosage. Therapiewoche 1982;32(44):5347-51.
66. Degitz K, Ochsendorf F. Pharmacotherapy of acne. Expert Opinion on Pharmacotherapy 2008;9(6):955-71.
67. Degreef H. Minocycline in the treatment of acne vulagris. Current Therapeutic Research 1983;33(1):8-13.
68. Del Rosso JQ. A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines. Cutis 2004;74(2):118-22.
69. Donadini A. Is topical antibiotic therapy associated with the same oral treatment useful in patients with acne? [Ha significato nell'acne l'impiego di un antibiotico topico nel corso di analoga terapia sistemica?]. Annali Italiani di Dermatologia Clinica e Sperimentale 1989;43(2):153-69.
70. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. British Journal of Dermatology 1990;122(2):233-44.
71. Eady EA, Jones CE, Gardner KJ, Taylor JP, Cove JH, Cunliffe WJ. Tetracycline-resistant propionibacteria from acne patients are cross resistant to doxycycline but sensitive to minocycline. British Journal of Dermatology 1993;128(5):556-60.
72. Fernandez-Obregon AC. Azithromycin for the treatment of acne. International Journal of Dermatology 2000;39(1):45-50.
73. Funt LS. Oral ibuprofen and minocycline for the treatment of resistant acne vulgaris. Journal of the American Academy of Dermatology 1985;13(3):524-5.
74. Goto M. Evaluation of minocycline (7-dimethylamino-6-demethyl-6-deoxytetracycline) in the dermatological field (Japanese). Japanese Journal of Antibiotics 1969;22(6):488-92.
75. Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in the treatment of acne. British Journal of Dermatology 1996;134(4):693-695.
76. Gruber F, Grubisic-Greblo H, Kastelan M, Brajac I, Lenkovic M, Zamolo G. Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa. Journal of Chemotherapy 1998;10(6):469-73.
77. Hughes BR, Murphy CE, Barnett J, Cunliffe WJ. Strategy of acne therapy with long-term antibiotics. British Journal of Dermatology 1989;121(5):623-8.
78. Jeanmougin M. Minocycline and benzoyl peroxide in the treatment of acne vulgaris: Results of a multicentre trial with 256 patients [Minocycline et peroxyde de benzoyle dans le traitement de l'acné: résultats d'une étude multicentrique sur 256 patients]. Comptes Rendus de Thérapeutique et de Pharmacologie Clinique 1987;5(50):3, 5, 7-9, 11.
79. Ketelbey JW. Acne and minocycline. New Zealand Medical Journal 1988;101(851):520.
80. Kircik LH. Doxycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications. Journal of Drugs in Dermatology 2010;9(11):1407-1411.
81. Kircik LH. Commentary: Doxycycline vs. minocycline for the management of acne. Journal of Drugs in Dermatology 2011;10(9):966.
82. Kligman AM. Comparison of a topical benzoyl peroxide gel, oral minocycline, oral doxycycline and a combination for suppression of P. acnes in acne patients. Journal of Dermatological Treatment 1998;9(3):187-191.
83. Knaggs HE, Layton AM, Cunliffe WJ. The role of oral minocycline and erythromycin in tetracycline therapy-resistant acne - a retrospective study and a review. Journal of Dermatological Treatment 1993;4(2):53-6.
84. Kurka M, Orfanos CE. Which antibiotics are helpful in acne? A review of the literature and personal test results with minocyclin (klinomycin) [Welche antibiotika helfen bei akne?]. Zeitschrift fur Hautkrankheiten 1976;51(2):45-54.
85. Laux B. Treatment of acne vulgaris [Behandlung der acne vulgaris: vergleichende klinische studie mit doxycyclin 50mg/d versus minocyclin 100mg/d]. Ärztliche Kosmetologie 1987;17(5):366-72.
86. Layton AM, Cunliffe WJ, Knaggs HE, MacDonald-Hull SP. The role of minocycline in therapy resistant acne (Abstract). British Journal of Dermatology 1992;127(suppl. 40):31.
87. Leyden JJ, McGinley KJ, Kligman AM. Tetracycline and minocycline treatment. Effects on skin-surface lipid levels and Propionibacterium acnes. Archives of Dermatology 1982;118(1):19-22.
88. Leyden JJ, Kaidbey K, Gans EH. The antimicrobial effects in vivo of minocycline, doxycycline and tetracycline in humans. Journal of Dermatological Treatment 1996;7(4):223-225.
89. Leyden JJ, Gans EH. The human in vivo antimicrobial effects of dual acne therapy: Oral Dynacin (minocycline HCl) plus topical Triaz (benzoyl peroxide special gel). Journal of Dermatological Treatment 1997;8(Suppl 2):S3-6.
90. Leyden J, Thiboutot DM, Shalita A, Webster G, Washenik K, Strober BE, et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicentre, double-blind, randomised parallel-group study. Archives of Dermatology 2006;142(5):605-612.
91. Lowy G. Minocycline and acne [Minociclina e acne]. Folha Medica 1982;85(1):539-40.
92. Luderschmidt C, Nissen H, Neubert U, Knuechel M. Newer methods for measuring therapeutic response in acne. Royal Society of Medicine Services International Congress & Symposium Series 1985;95:131-40.
93. Millar ED, Jolliffe DS, Leigh AP. A general practice study investigating the effect of minocycline (Minocin) 50 mg bd for 12 weeks in the treatment of acne vulgaris. British Journal of Clinical Practice 1987;41(8):882-6.
94. Minami K, Tashiro M. Comparison of clinical effects of minocycline and demethylchlortetracycline in the dermatological field (Japanese). Japanese Journal of Antibiotics 1969;22(6):493-500.
95. Miura Y, Mizumoto T, Shibaki H. Minocycline (Japanese). Japanese Journal of Antibiotics 1969;22(6):483-7.
96. Mizuno K. Clinical experiences of minocycline on acne (Japanese). Nishinihon Journal of Dermatology 1980;42(5):874-7.
97. Mobacken H. Oral tetracycline-treatment of acne. Rapid facial improvement, but back lesions are more difficult to treat (Swedish). Lakartidningen 1993;90(34):2755-7.
98. Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacological Research 2011;63(2):130-45.
99. Montero ED. Minocycline (therapeutic evaluation in various skin conditions) [Minociclina (ensayo therapeutico en diversas dermatosis)]. Medicina Cutanea 1972;6:105.
100. Ng CH, Tam MM, Celi E, Tate B, Schweitzer I. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australasian Journal of Dermatology 2002;43(4):262-8.
101. Nishijima S, Kurokawa I, Kawabata S. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents. Journal of International Medical Research 1996;24(6):473-7.
102. Ochsendorf F. Minocycline in acne vulgaris: benefits and risks. American Journal of Clinical Dermatology 2010;11(5):327-41.
103. Pablo GM, Fulton JE. Sebum: analysis by infrared spectroscopy. II. The suppression of fatty acids by systemically administered antibiotics. Archives of Dermatology 1975;111(6):734-5.
104. Pavone P. Azithromycin versus minocycline in the treatment of acne vulgaris [Azitromicina versus minociclina nel trattamento dell' acne volgare]. Chronica Dermatologica 1994;4(5):867-72.
105. Randazzo SD, Lo Presti V, Caruso A. Clinical evaluation of combined minocycline streptokinase-streptodornase treatment in acne [Valutazione clinica del trattamento con minociclina piu streptochinasi-streptodornasi nell'acne volgare]. Annali Italiani di Dermatologia Clinica e Sperimentale 1981;35(1):67-77.
106. Reisner RM. Antibiotic and anti-inflammatory therapy of acne. Dermatologic Clinics 1983;1(3):385-97.
107. Rocco D, Pagnini U, Rocco A. Effect of cefuroxime axetil in the treatment of papulo-pustular acne [L'acetossietilcefuroxime nel trattamento dell'acne papulo-pustulosa]. Giornale Italiano di Dermatologia e Venereologia 1998;133(6):465-8.
108. Rossman RE. Minocycline treatment of tetracycline-resistant and tetracycline-responsive acne vulgaris. Cutis 1981;27(2):196-7, 201, 207.
109. Sanchez AT, Olivera RMP, Sanchez GMDO, Dorantes GL. Quality of life and psychological symptoms in patients with severe acne in treatment with isotretinoin [Calidad de vida y sintomas psicologicos en pacientes con acne severo tratados con isotretinoina]. Dermatologia Revista Mexicana 2006;50(4):121-6.
110. Savage LJ, Layton AM. Treating acne vulgaris: systemic, local and combination therapy. Expert Review of Clinical Pharmacology 2010;3(4):563-80.
111. Schulz H, Stauder G. Oral minocycline treatment for acne vulagris and for rosacea [Orale minocyclintherapie der akne vulgaris und der rosacea]. Zeitschrift für Allgemeinmedizin 1984;60(24):1033-7.
112. Shalita AR, Webster GF, Wortzman MS, Nelson DB. Doxycycline vs. minocycline for the management of acne. Journal of Drugs in Dermatology 2011;10(9):965-6.
113. Sloan B, Scheinfeld N. The use and safety of doxycycline hyclate and other second-generation tetracyclines. Expert Opinion on Drug Safety 2008;7(5):571-7.
114. Takeuchi S, Morishita M. Treatment of acne vulgaris with minomycin capsules (50mg) (Japanese). Nishinihon Journal of Dermatology 1980;42(5):870-3.
115. Thiboutot D. Rethinking treatment of acne in the severe patient. Journal of Drugs in Dermatology 2011;10(6):s8-s12.
116. Thielitz A, Gollnick H. Overview of new therapeutic developments for acne. Expert Review of Dermatology 2009;4(1):55-65.
117. Unna PJ, Ischler T. Pragmatic treatment of juvenile acne [Pragmatische therapie der acne juvenilis]. Zeitschrift für Allgemeinmedizin 1989;65(34):860-4.
118. Villano PA. Minocycline in the treatment of acne vulgaris [La minociclina nel trattamento dell'acne volgare]. Dermatologia Clinica 1984;4(1):71-4.
119. Zaenglein AL, Thiboutot DM. Expert committee recommendations for acne management. Pediatrics 2006;118(3):1188-99.
120. Kawana S, Ueno T, Shimoda T. Efficacy of long-term administration of roxithromycin (Rulid) in treatment of acne: comparison with minocycline hydrochloride. Nishinihon Journal of Dermatology 2007;69(4):424-7.
121. Revuz J, Amblard P, Dreno B, Lorette G, Ortonne JP, Puissant A. Efficacy of zinc gluconate in the treatment of inflammatory acne [Efficacite du gluconate de zinc dans le traitement de l'acne inflammatoire]. Abstr Dermatol 1990;77:2-4.
122. Revuz J (11, Chaussée de la Muette, Paris, France) [personal communication] [Evaluation comparative en double aveugle de trois strategies de traitement de l'acne avec minocycline microgranules 100mg/jour associee au peroxyde de benzoyle (unpublished)]. Letter to S Garner (NICE, London, UK) 11 October 1993.
123. Yoon YH, Ro BI, Seo SJ, Kim MN, Hong CK. Comparison of cost and effectiveness between isotretinoin versus minocycline in the treatment of patients with acne. Korean Journal of Dermatology 2005;43(9):1200-6.
124. EUCTR2008-002642-32-GB A Placebo Controlled, Single-Blind, Pilot Clinical Evaluation of the Effect of a Novel Antibiotic Preparation on the Cutaneous Microflora and Clinical Signs in Acne Patients. //apps.who.int/trialsearch/trial.aspx?trialid=EUCTR2008-002642-32-GB Accessed 16 April 2012.
125. NCT00240513 Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin. clinicaltrials.gov/ct2/show/NCT00240513?term=NCT00240513&rank=1 Accessed 16 April 2012.
126. NCT00392223 Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne. clinicaltrials.gov/ct2/show/NCT00392223?term=NCT00392223&rank=1 Accessed 16 April 2012.
127. NCT00988026 Safety and Efficacy Comparison of Minocycline Microgranules Versus Lymecycline in the Treatment of Mild to Moderate Acne (MXMIN-001). clinicaltrials.gov/ct2/show/NCT00988026 Accessed 16 April 2012.
128. NCT01206348 Combination Treatment for Moderate to Severe Acne. clinicaltrials.gov/ct2/show/NCT01206348?term=NCT01206348&rank=1 Accessed 16 April 2012.
129. NCT01362010 Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients. clinicaltrials.gov/ct2/show/NCT01362010?term=NCT01362010&rank=1 Accessed 16 April 2012.
130. Editorial Fewer adverse effects with doxycycline than with minocycline. Prescrire International 2009;18(103):213.
131. Agruh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycyclines. Journal of Antimicrobial Chemotherapy 2006;58(2):256-265.
132. Allen JC. Minocycline. Annals of Internal Medicine 1976;85(4):482-7.
133. Angulo JM, Sigal LH, Espinoza LR. Coexistent minocycline-induced systematic lupus erythematosus and autoimmune hepatitis. Seminars in Arthritis & Rheumatism 1998;28(3):187-92.
134. Arowojolu AO, Gallo MF, Lopez LM, Grimes DA, Garner SE. Combined oral contraceptive pills for treatment of acne. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD004425.pub4]
135. Aubin F, Blanc D, Guinchard C, Agache P. Absence of minocycline in sebum?. Journal of Dermatology 1989;16(5):369-73.
136. Basler RSW. Minocycline therapy for acne. Archives of Dermatology 1979;115(12):1391.
137. Beneton N, Bocquet H, Cosnes A, Revuz J, Roujeau JC. Benefit-risk assessment of acne therapies. Lancet 1997;349(9060):1252.
138. Brock P (Wyeth Laboratories, Havant, UK) [[personal communication]]. Letter to S Garner (NICE, London UK) 21 October 1998.
139. Burke BM, Cunliffe WJ. The assessment of acne vulgaris- the Leeds technique. British Journal of Dermatology 1984;111(1):83-92.
140. Chopra I, Hawkey PM, Hinton M. Tetracyclines, molecular and clinical aspects. Journal of Antimicrobial Chemotherapy 1992;29(3):245-77.
141. Coates P, Eady EA, Cove JH. Antibiotic-resistant acne. Current Practice of Medicine 1999;2(6):121-3.
142. Colaizzi JL, Klink PR. pH-partition behaviour of tetracyclines. Journal of Pharmaceutical Sciences 1969;58(10):1184-9.
143. Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Archives of Dermatology 1979;115(5):571-5.
144. Crosson J, Stillman MT. Minocycline-related lupus erythematosus with associated liver disease. Journal of the American Academy of Dermatology 1997;36(5 Suppl 2):867-8.
145. Cunliffe WJ. Acne (Focal Points in Dermatology). London: Martin Dunitz, 1989.
146. Cunliffe WJ. Minocycline for acne. Doctors should not change the way they prescribe for acne. BMJ 1996;312(7038):1101.
147. Davies MG, Kersey PJW. Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ 1989;298(6686):1523-4.
148. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. British Journal of Dermatology 1990;122(2):233-44.
149. Eady EA, Cove JH, Joanes DN, Cunliffe WJ. Topical antibiotics for the treatment of acne vulgaris: a critical evaluation of the literature on their clinical benefit and comparative efficacy. Journal of Dermatological Treatment 1990;1(4):215-26.
150. Fanning WL, Gump DW, Sofferman RA. Side effects of minocycline: a double blind study. Antimicrobial Agents and Chemotherapy 1977;11(4):712-7.
151. Fay BT, Whiddon AP, Puumala S, Black N, O'Dell JR, Mikuls TR. Minocycline-induced hyperpigmentation in rheumatoid arthritis. Journal of Clinical Rheumatology 2008;14(1):17-20.
152. Ferguson JJ, Jenkins MGV, Field J. Paper in BMJ influenced prescribing of minocycline. BMJ 1998;316(7124):72-3.
153. Ferner RE, Moss C. Minocycline for acne. BMJ 1996;312(7024):138.
154. Fessler B. Tetracycline instead of minocycline in antibiotic therapy of acne? [Antibiotische Aknetherapie. Tetracyclin statt Minocyclin?]. Deutsche Apotheker Zeitung 1996;136(31):35-6.
155. Gardner KJ, Eady EA, Cove JH, Taylor JP, Cunliffe WJ. Comparison of serum antibiotic levels in acne patients receiving the standard or a modified release formulation of minocycline hydrochloride. Clinical & Experimental Dermatology 1997;22(2):72-6.
156. Glass GV, McGaw B, Smith, ML Meta-analysis in social research: individual and neighbourhood reactions. Beverly Hills, California: Sage Publications, Inc, 1981:77-91.
157. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996;312(7024):169-72.
158. Goulden V, Clarke SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. British Journal of Dermatology 1997;136(1):66-70.
159. Grasset L, Guy C, Ollagnier M. Cyclines and acne: pay attention to adverse drug reactions! A recent literature review [Cyclines et acne: attention aux effets indesirables! Aspects recents de la litterature]. Revue de Medecine Interne 2003; Vol. 24, issue 5:305-16.
160. Gump DW, Ashikaga T, Fink TJ, Radin AM. Side effects of minocycine: different dosage regimens. Antimicrobial Agents & Chemotherapy 1977;12(5):642-6.
161. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Archives of Dermatology 1996;132(8):934-9.
162. Lawrenson RA, Seaman HE, Sundstrom A, Williams TJ, Farmer RDT. Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilence data. Drug Safety 2000;23(4):333-49.
163. Lebrun-Vignes B, Kreft-Jais C, Castot A, Chosidow O. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. British Journal of Dermatology 2012;166:1333-41.
164. Leyden JJ. Absorption of minocycline hydrochloride and tetracycline hydrochloride. Effect of food, milk and iron. Journal of the American Academy of Dermatology 1985;12(2 1):308-12.
165. Leyden JJ. Therapy for acne vulgaris. New England Journal of Medicine 1997;336(16):1156-62.
166. Luderschmidt C, Nissen H, Neubert U, Knuechel M. Newer methods for measuring therapeutic response in acne. Royal Society of Medicine Services International Congress & Symposium Series 1985;95:131-40.
167. Macdonald H, Kelly RG, Allen ES. Pharmacokinetic studies on minocycline in man. Clinical Pharmacology & Therapeutics 1973;14(5):852-61.
168. MacNeil M, Haase DA, Tremaine R, Marrie TJ. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. Journal of the American Academy of Dermatology 1997;36(2 Suppl):347-50.
169. Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. British Journal of Dermatology 2007;157(3):540-6.
170. Margolis DJ, Fanelli M, Hoffstad O, Lewis JD. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. American Journal of Gastroenterology 2010;105(12):2610-6.
171. Marzo-Ortega H, Baxter K, Strauss RM, Drysdale S, Griffiths B, Misbah SA, et al. Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. British Journal of Dermatology 2007;156(5):1005-9.
172. Meyer FP. Minocycline for acne. Food reduces minocycline's bioavailability. BMJ 1996;312(7038):1101.
173. Ortonne JP. Oral isotretinoin treatment policy. Do we all agree?. Dermatology 1997;195(Suppl 1):34-7.
174. Rothman KF, Lucky AW. Acne vulgaris. Advances in Dermatology 1993;8:347-74, 75.
175. Ruef C, Blaser J, Maurer P, Keller H, Follath F. Miscellaneous antibiotics. In: Dukes MNG editor(s). Meyler's Side Effects of Drugs. 13. B.V: Elsevier Science, 1996:725-63.
176. Saurat JH. Oral isotretinoin. Where now, where next!. Dermatology 1997;195(Suppl 1):1-3.
177. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus: a systematic review. Dermatology 2000;200(3):223-31.
178. Schoonen WM, Thomas SL, Somers EC, Smeeth L, Kim J, Evans S, et al. Do selected drugs increase the risk of lupus? A matched case-control study. British Journal of Clinical Pharmacology 2010;70(4):588-96.
179. Seaman HE, Lawrenson RA, Williams TJ, MacRae KD, Farmer RDT. The risk of liver damage associated with minocycline: a comparative study. Journal of Clinical Pharmacology 2001;41(8):852-60.
180. Seukeran DC, Eady EA, Cunliffe WJ, Beneton N, Bocquet H, Cosnes A, et al. Benefit-risk assessment of acne therapies. Lancet 1997;349(9060):1251-2.
181. Shaheen B, Gonzalez M. A microbial aetiology of acne: what is the evidence?. British Journal of Dermatology 2011;165(3):474-85.
182. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Archives of Dermatology 1997; Vol. 133, issue 10:1224-30.
183. Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clinical Therapeutics 2005; Vol. 27, issue 9:1329-42.
184. Soory M. A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: a literature review. Open Dent J 2008;2:5-12.
185. Sturkenboom MCJM, Meier CR, Jick H, Stricker BHC. Minocycline and lupuslike syndrome in acne patients. Archives of Internal Medicine 1999;159(5):493-7.
186. Ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Annals of Pharmacotherapy 2002;36(1):130-47. [PUBMED: 11816242]
187. Anonymous A proposal for the structured reporting of randomised controlled trials. The Standards of Reporting Trials Group. JAMA 1994;272(24):1926-31.
188. Walsh S, Creamer D. Minocycline in the management of acne vulgaris: the challenge of conveying pharmacovigilence data to primary care. British Journal of Dermatology 2012;166:1155-1159.
189. Williams DN, Laughlin LW, Lee YH. Minocycline: possible vestibular side-effects. Lancet 1974;2(7883):744-6.
190. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012;379(9813):361-72.
191. Wright AL, Colver GB. Tetracyclines - How safe are they?. Clinical & Experimental Dermatology 1988;13(2):57-61.